Searchable abstracts of presentations at key conferences in endocrinology

ea0020p579 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Empty sella and primary autoimmune hypothyroidism

Garcia-Centeno Rogelio , Suarez-Llanos Jose-Pablo , Fernandez-Fernandez Elisa , Andia-Melero Victor , Sambo Marcel , Sanchez Petra , Jara-Albarran Antonino

Objective: To assess the association between empty sella (ES) and primary autoimmune hypothyroidism, and the possibility of a common pathogenesis.Patients and methods: We retrospectively studied all patients with presumed ES diagnosed in the last 20 years, most of whom were treated and followed up by our Endocrinology Department. Subjects with a known aetiology were excluded. Incomplete records or those with a doubtful diagnosis were also excluded. A tot...

ea0037ep678 | Pituitary: basic and neuroendocrinology | ECE2015

Long-term safety, tolerability, and efficacy of extended release somatostatin analogues

Gonzalez Javier , Garcia-Centeno Rogelio , Arnoriaga Maria , Picallo Maria , Ramirez Maria Laura , Andia Victor Manuel , Olmedilla Yoko Lucia , Lopez Aurelio , Monereo Susana

Introduction: The main indications for the somatostatin analogues (SST-A) are acromegalies and/or neuroendocrine tumors. They can increase fecal fats, which could lead to the loss of fat soluble vitamins. There are few published studies showing the effects of the long-term use.Methods: Retrospective study of patients with SST-A indicated from our endocrinology department in the last 10 years. We analysed indications and different epidemiological, clinica...

ea0081ep695 | Pituitary and Neuroendocrinology | ECE2022

Epidemiological description of 20 years of experience in the management of insulinomas in a third level hospital

Maricel Rivas Montenegro Alejandra , Ramos Roberto Jose An ez , Belinchon Sergio Santos , Gonzalez Fernandez Laura , Moreno Diego Mun oz , Fernandez Fernandez Elisa , Salas Marcel Sambo , Hualpa Juan Carlos Percovich , Gonzalez Albarran Olga , Garcia Centeno Rogelio

Introduction: Insulinoma, despite its low incidence of 0.4%, it is the most common functioning pancreatic neuroendocrine tumor. Most are benign, solitary and sporadic. Around 10% can be malignant and 5-10% are part of MEN-1. On certain occasions, the differential diagnosis is difficult when there is a history of Diabetes Mellitus (DM). Our objective was to describe clinical-epidemiological data and its diagnostic-therapeutic management.Materials and Meth...

ea0032p868 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

Sesmilo Gemma , Resmini Eugenia , Bernabeu Ignacio , Aller Javier , Soto Alfonso , Marazuela Monica , Mora Mireia , Pico Antonio , Fajardo Carmen , Torres Elena , Alvarez-Escola Cristina , Garcia-Centeno Rogelio , Blanco Concepcion , Camara Rosa , Gaztambide Sonia , Salinas Isabel , Del Pozo Carlos , Castells Ignasi , Villabona Carles , Webb Susan

Pegvisomant (peg) is an effective treatment for acromegaly.Aim: To investigate the prevalence of escape and the incidence of lipodystrophy with peg treatment.Methods: Multicenter retrospective study. Escape was defined as loss of control in patients previously controlled under a stable dose of peg, without any other treatment change. Lipodystrophy was defined as either hypertrophy or atrophy of subcutaneous tissue in areas of drug ...